761 results on '"Scheetz, Marc H."'
Search Results
2. Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams
3. Past, Present, and Future Biomarkers of Kidney Function and Injury: The Relationship With Antibiotics
4. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
5. International survey of antibiotic dosing and monitoring in adult intensive care units
6. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
7. Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults
8. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
9. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
10. Antimicrobial Therapeutic Drug Monitoring in critically ill adult patients -an international perspective on access, utilisation, and barriers.
11. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
12. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
13. Meta-analysis on safety of standard vs prolonged infusion of beta-lactams
14. Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
15. A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19
16. Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
17. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
18. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
19. 2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
20. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
21. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study
22. Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
23. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
24. Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
25. Antimicrobial therapeutic drug monitoring in critically ill adult patients – An international perspective on access, utilisation, and barriers
26. Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials
27. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model.
28. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
29. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
30. Microsampling Assays for Pharmacokinetic Analysis and Therapeutic Drug Monitoring of Antimicrobial Drugs in Children: A Critical Review
31. Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model
32. International survey of antibiotic dosing and monitoring in adult intensive care units
33. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection
34. Vancomycin Prescribing and Therapeutic Drug Monitoring in Children With and Without Acute Kidney Injury After Cardiac Arrest
35. Engaging Pharmacy Students in Research Through Near-Peer Training
36. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
37. Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
38. Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption
39. Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children.
40. Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy.
41. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
42. A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement
43. Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
44. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model
45. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics : Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
46. Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections
47. Periarrest intestinal bacterial translocation and resuscitation outcome
48. An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity
49. Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
50. International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.